UCSF Health has performed 150 robotic focal high-intensity focused ultrasound (HIFU) procedures for patients living with prostate cancer, becoming the first on the West Coast and the first UC Health System to reach that milestone.
The Arc Institute, a privately-funded research organization in Palo Alto, is giving nine UCSF faculty members guaranteed funding for up to eight years to doggedly pursue their boldest research plans.
Recent findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer were reported in the Journal of Nuclear Medicine.
In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies.
Lena Winestone, MD, MSHP, UCSF Assistant Professor of Pediatrics, studies access to care for children with cancer and says that insights into racial, ethnic, and socioeconomic disparities can reveal ways for interventions to better support vulnerable populations.
From medical school, to cancer research coordinator, to PhD program, the pathway of scholar Sarah Kutika Nyagabona MD, Mmed Clinical Oncology, exemplifies the power of collaboration and mentorship in shaping a new generation of oncologists across the globe.
Eleven investigators and teams were awarded grants in support of cancer research projects in the spring 2023 cycle of the UCSF Resource Allocation Program (RAP).
Regionally, UCSF Medical Center was listed as the best hospital for cancer care in Northern California.
A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler
In a Q&A, Dr. Karin Gaensler discusses the ongoing development of a safe and effective vaccine to improve relapse-free survival for patients with acute myelogenous leukemia (AML).